HILLSIDE, N.J., Feb. 26, 2008 (PRIME NEWSWIRE) -- Integrated BioPharma, Inc. (Nasdaq:INBP) announced today that Carl DeSantis, the founder, principal owner and former Chairman and CEO of Rexall Sundown, Inc., has become the Co-Chairman of the Company to lead the next stage of development of its liquid nutritional and vitamin businesses weighted heavily toward nutraceutical products. Last week, Mr. DeSantis increased his beneficial ownership of equity and debt in the Company by $7.5 million with an investment of $3.0 million in the Company’s Series C Convertible Preferred Stock and the purchase of a $4.5 million Convertible Note. At the same time, Imperium Master Fund, Ltd. purchased $3.0 million of the Company’s Series C Convertible Preferred Stock and a $7.0 million Secured Note.
